GB-5267 An investigational MUC16-targeted, IL-18-armored CAR T-cell therapy in development for metastatic ovarian cancer.
Visit productCosigns Received
Be the first Cosign
Put your name behind GB-5267.
Add it to your Products I use list and share why you use it.